Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

30.10.2017

1 Am J Surg Pathol
1 Anticancer Res
3 BJU Int
1 Chin J Cancer
5 Clin Genitourin Cancer
1 Hinyokika Kiyo
6 J Urol
1 Mayo Clin Proc
1 Med Oncol
1 World J Urol



    Am J Surg Pathol

  1. BORHAN WM, Cimino-Mathews AM, Montgomery EA, Epstein JI, et al
    Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
    Am J Surg Pathol. 2017;41:1570-1575.
    >> Share


    Anticancer Res

  2. SCHINZARI G, Monterisi S, Pierconti F, Nazzicone G, et al
    Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.
    Anticancer Res. 2017;37:6453-6458.
    >> Share


    BJU Int

  3. HUDDART RA, Birtle A, Maynard L, Beresford M, et al
    Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
    BJU Int. 2017;120:639-650.
    >> Share

  4. AHMADI N, Clifford TG, Miranda G, Cai J, et al
    Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion.
    BJU Int. 2017;120:689-694.
    >> Share

  5. XIA L, Taylor BL, Newton AD, Malhotra A, et al
    Early Discharge and Post-Discharge Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
    BJU Int. 2017 Oct 24. doi: 10.1111/bju.14058.
    >> Share


    Chin J Cancer

  6. BI X, Wu Z, Han H, Zhou F, et al
    Clinical comparison of patients with benign urachal masses versus urachal carcinomas.
    Chin J Cancer. 2017;36:2.
    >> Share


    Clin Genitourin Cancer

  7. MOSCHINI M, Soria F, Klatte T, Wirth GJ, et al
    Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy.
    Clin Genitourin Cancer. 2017;15:e267-e273.
    >> Share

  8. SINGH R, Ansari JA, Maurya N, Mandhani A, et al
    Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Clin Genitourin Cancer. 2017;15:e187-e197.
    >> Share

  9. CARAS RJ, Lustik MB, Kern SQ, McMann LP, et al
    Preoperative Albumin Is Predictive of Early Postoperative Morbidity and Mortality in Common Urologic Oncologic Surgeries.
    Clin Genitourin Cancer. 2017;15:e255-e262.
    >> Share

  10. MONN MF, Jaqua KR, Bihrle R, Cheng L, et al
    Primary Choriocarcinoma of the Bladder: A Case Report and Review of Literature.
    Clin Genitourin Cancer. 2017;15:188-191.
    >> Share

  11. KHORRAMI MH, Javid A, Izadpanahi MH, Alizadeh F, et al
    Efficacy of Long-Acting Octreotide on Reducing Mucus Production in Patients With Ileal Neobladder.
    Clin Genitourin Cancer. 2017;15:e9-e13.
    >> Share


    Hinyokika Kiyo

  12. UEMURA K, Namura K, Umemoto S, Matsubara O, et al
    [A Case of Squamous Cell Carcinoma in Bladder Diverticulum Producing Granulocyte Colony Stimulating Factor].
    Hinyokika Kiyo. 2017;63:211-215.
    >> Share


    J Urol

  13. ATALA A
    Re: Profiling of Long Non-Coding RNAs Identifies LINC00958 and LINC01296 as Candidate Oncogenes in Bladder Cancer.
    J Urol. 2017;198:983-985.
    >> Share

  14. ATALA A
    Re: Loss of Tumor Suppressor KDM6A Amplifies PRC2-Regulated Transcriptional Repression in Bladder Cancer and Can be Targeted through Inhibition of EZH2.
    J Urol. 2017;198:984-985.
    >> Share

  15. CHANG SS
    Re: Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-Muscle Invasive Bladder Cancer Patients.
    J Urol. 2017;198:979-980.
    >> Share

  16. ATALA A
    Re: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer.
    J Urol. 2017;198:985.
    >> Share

  17. WALLACE E, Higuchi R, Satya M, McCann L, et al
    Development of a 90-minute integrated non-invasive urinary assay for bladder cancer detection.
    J Urol. 2017 Oct 20. pii: S0022-5347(17)77760-9. doi: 10.1016/j.juro.2017.
    >> Share

  18. CHANG SS
    Re: Anti-Inflammatory Use May Not Negatively Impact Oncologic Outcomes following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2017;198:978-980.
    >> Share


    Mayo Clin Proc

  19. GIRIDHAR KV, Kohli M
    Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer.
    Mayo Clin Proc. 2017;92:1564-1582.
    >> Share


    Med Oncol

  20. HAKOZAKI K, Kikuchi E, Fukumoto K, Shirotake S, et al
    Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy.
    Med Oncol. 2017;34:187.
    >> Share


    World J Urol

  21. BACH T, Bastian PJ, Blana A, Kaminsky A, et al
    Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
    World J Urol. 2017;35:737-744.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016